MA43883A - Dã‰rivã‰s hã‰tã‰rocycliques antibactã‰riens - Google Patents
Dã‰rivã‰s hã‰tã‰rocycliques antibactã‰riensInfo
- Publication number
- MA43883A MA43883A MA043883A MA43883A MA43883A MA 43883 A MA43883 A MA 43883A MA 043883 A MA043883 A MA 043883A MA 43883 A MA43883 A MA 43883A MA 43883 A MA43883 A MA 43883A
- Authority
- MA
- Morocco
- Prior art keywords
- hospital
- antibacterial
- derivatives
- hospital derivatives
- antibacterial hospital
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2015069837 | 2015-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43883A true MA43883A (fr) | 2018-12-05 |
Family
ID=56893949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043883A MA43883A (fr) | 2015-08-31 | 2016-08-30 | Dã‰rivã‰s hã‰tã‰rocycliques antibactã‰riens |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20180251434A1 (fr) |
| EP (1) | EP3344609A1 (fr) |
| JP (1) | JP2018527349A (fr) |
| KR (1) | KR20180043355A (fr) |
| CN (1) | CN107922361A (fr) |
| AR (1) | AR105848A1 (fr) |
| CA (1) | CA2989968A1 (fr) |
| MA (1) | MA43883A (fr) |
| TW (1) | TW201718529A (fr) |
| WO (1) | WO2017037039A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| AR105646A1 (es) | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
| AR105889A1 (es) | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2694481B1 (fr) * | 2011-04-08 | 2015-12-30 | Pfizer Inc | Dérivés d'imidazole, de pyrazole et de triazole, utiles en tant qu'agents antibactériens |
| EP2694488B1 (fr) * | 2011-04-08 | 2014-11-12 | Pfizer Inc | Dérivés d'isoxazole utiles en tant qu'agents antibactériens |
| AR097617A1 (es) * | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
| JP6407288B2 (ja) * | 2013-12-19 | 2018-10-17 | イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | 抗菌性１ｈ−インダゾール及び１ｈ−インドール誘導体 |
| AR099612A1 (es) * | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| WO2016079688A1 (fr) * | 2014-11-19 | 2016-05-26 | Actelion Pharmaceuticals Ltd | Dérivés de benzothiazole antibactériens |
-
2016
- 2016-08-29 AR ARP160102629A patent/AR105848A1/es unknown
- 2016-08-30 MA MA043883A patent/MA43883A/fr unknown
- 2016-08-30 CN CN201680048834.7A patent/CN107922361A/zh active Pending
- 2016-08-30 EP EP16763225.6A patent/EP3344609A1/fr not_active Withdrawn
- 2016-08-30 CA CA2989968A patent/CA2989968A1/fr not_active Abandoned
- 2016-08-30 US US15/755,411 patent/US20180251434A1/en not_active Abandoned
- 2016-08-30 TW TW105127785A patent/TW201718529A/zh unknown
- 2016-08-30 WO PCT/EP2016/070362 patent/WO2017037039A1/fr not_active Ceased
- 2016-08-30 JP JP2018511154A patent/JP2018527349A/ja active Pending
- 2016-08-30 KR KR1020187008546A patent/KR20180043355A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP3344609A1 (fr) | 2018-07-11 |
| US20180251434A1 (en) | 2018-09-06 |
| KR20180043355A (ko) | 2018-04-27 |
| CA2989968A1 (fr) | 2017-03-09 |
| WO2017037039A1 (fr) | 2017-03-09 |
| AR105848A1 (es) | 2017-11-15 |
| JP2018527349A (ja) | 2018-09-20 |
| CN107922361A (zh) | 2018-04-17 |
| TW201718529A (zh) | 2017-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20230006I1 (fi) | Vutrisiraani | |
| EP4226898C0 (fr) | Unité actionneur-amortisseur | |
| DK3316969T3 (da) | Antibakterielle forbindelser | |
| EP3291824A4 (fr) | Thérapie antimicrobienne | |
| PL3345230T3 (pl) | Podwójny perowskit | |
| EP3360001A4 (fr) | Visiocasque | |
| DK4032440T3 (da) | Låganordning | |
| EP3352543A4 (fr) | Boîtier | |
| FR3039337B1 (fr) | Motoreducteur compact | |
| DK3330593T3 (da) | Halo-lysenhed | |
| EP3395868A4 (fr) | Structure | |
| EP3337164A4 (fr) | Visiocasque | |
| BR112017014838A2 (pt) | benzoxaboróis microbicidas | |
| DK3100747T3 (da) | Steriliseret arbejdssystem | |
| EP3343603A4 (fr) | Structure | |
| BR112017014839A2 (pt) | novos microbicidas | |
| HUE054351T2 (hu) | Vegyületek | |
| EP3325363A4 (fr) | Patin ondulé | |
| EP3373875A4 (fr) | Bandage | |
| DK3597189T3 (da) | Krystallinske forbindelser | |
| EP3352542A4 (fr) | Boîtier | |
| BR112016018442A2 (pt) | agentes antibacterianos | |
| EP3352540A4 (fr) | Boîtier | |
| EP3352541A4 (fr) | Boîtier | |
| LT3331885T (lt) | Junginiai |